Parainfluenza Infection
2 clinical trials · Condition
◉ Watch Parainfluenza Infection
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults (NCT06984094) | Clover Biopharmaceuticals AUS Pty | 2025-06-18 |
| DAS181 in Patients With Parainfluenza (NCT01441024) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-07-14 |
Track Parainfluenza Infection automatically
Every clearance here is in the API, with alerts when new ones post.